A Phase I Trial Evaluating the Combination of Trametinib and Everolimus in Pediatric and Young Adult Patients with Recurrent Low Grade Gliomas - 12797sc

Grant

Awarded By

Total Award Amount

  • 15000.00

    • Direct Costs

  • 15000.00

    • Sponsor Award Id

  • 12797SC-PNOC021

    • Contributor

  • Elizabeth Alva   Investigator  
  • Girish Dhall   Principal Investigator  
  • Gregory Friedman M.D.   Investigator  
  • Laura Metrock   Investigator